Through a series of clinical correlation analysis, it was found that 7 immune genes (SLC10A2, CXCL3, IGHV5-51, INHBA, STC1, UCN, and OXTR) were correlated with clinical prognosis and risk score of patients with COAD. This evidence concerns the gene CXCL3 and colon adenocarcinoma.